Methods | D: crossover C: unclear B: double WD: 15/45 J: 1‐1‐0 DU: 4w/2x3m/‐ | |
Participants | N: 45/30 D: 15 migraine with, 15 without aura C: Ad Hoc F: 83% A: 18‐59 years DU: 1‐50 years S: neurology department in Denmark | |
Interventions | P: 120 mg C: Placebo | |
Outcomes | R: 14/30 vs. 9/30 F: 1.03 (sd 1.02) vs. 1.33 (1.15) attacks per week AU: similar in both groups HI: not reported AEs: not reported Dropouts‐AEs: 0/45 vs. 2/45 V: + | |
Notes | High dropout rate Responder rates and attack frequency calculated from single patient data presented in the publication | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Unclear risk | B ‐ Unclear |